IP Verse

Method For Purifying Protein Using Amino Acid - EP2583973

The patent EP2583973 was granted to Kyowa Hakko Kirin on Mar 21, 2018. The application was originally filed on Jun 20, 2011 under application number EP11798094A. The patent is currently recorded with a legal status of "Revoked".

EP2583973

KYOWA HAKKO KIRIN
Application Number
EP11798094A
Filing Date
Jun 20, 2011
Status
Revoked
Dec 11, 2023
Grant Date
Mar 21, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBDec 19, 2018MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBADMISSIBLE

Patent Citations (32) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONJPH05504579
EXAMINATIONUS2005176109
EXAMINATIONUS2006030696
EXAMINATIONUS2007054390
EXAMINATIONUS2008064861
EXAMINATIONUS2008312425
EXAMINATIONUS2009286283
EXAMINATIONUS5429746
EXAMINATIONWO2010056550
INTERNATIONAL-SEARCH-REPORTJP2009522580
INTERNATIONAL-SEARCH-REPORTWO2010019493
OPPOSITIONEP2182003
OPPOSITIONEP2383336
OPPOSITIONUS2005176109
OPPOSITIONUS2006030696
OPPOSITIONUS2006257972
OPPOSITIONUS2007054390
OPPOSITIONUS2008064861
OPPOSITIONUS2008312425
OPPOSITIONUS2009162372
OPPOSITIONUS2009318674
OPPOSITIONUS5429746
OPPOSITIONWO2005051994
OPPOSITIONWO2006023403
OPPOSITIONWO2006023420
OPPOSITIONWO2009025300
OPPOSITIONWO2010019493
OPPOSITIONWO2010056550
OPPOSITIONWO2010084851
SEARCHUS2006257972
SEARCHUS2009162372
SEARCHUS2009318674

Non-Patent Literature (NPL) Citations (17) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- PROTEIN EXPRESSION AND PURIFICATION, (2004), vol. 36, pages 244 - 248-
DESCRIPTION- PROTEIN EXPRESSION AND PURIFICATION, (2007), vol. 54, pages 110 - 116-
EXAMINATION- JUNGBAUER A ET AL, "Pilot scale production of a human monoclonal antibody against human immunodeficiency virus", JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, AMSTERDAM, NL, (19890101), vol. 19, no. 2/03, doi:10.1016/0165-022X(89)90029-8, ISSN 0165-022X, pages 223 - 240, XP002114282
INTERNATIONAL-SEARCH-REPORT- ARAKAWA,T. ET AL., "The effects of arginine on protein binding and elution in hydrophobic interaction and ion-exchange chromatography", PROTEIN EXPR.PURIF., (2007), vol. 54, no. 1, pages 110 - 116, XP022056642
OPPOSITION- "Antibody Purification Handbook", GE Healthcare Bio-Sciences, (20071200), pages 5, 6, 47, 48, 66 - 70, 92, 105 and 106, XP055539611-
OPPOSITION- "Ion Exchange Chromatography & Chromatofocusing Handbook", Amersham Biosciences, (20011000), pages 34 , 35, 46, 47 and 129 - 139, XP055539559-
OPPOSITION- "Leaflet on CaptoAdhere", GE Healthcare Bio-Sciences, (20070000), pages 1 - 6, XP055539565-
OPPOSITION- LEBRETON, G. et al., "Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies", BioPharm International, (20090302), vol. 6, no. 2, pages 665 - 673, XP055539541-
OPPOSITION- PINGOUD, A. et al., "Arbeitsmethoden der Biochemie", Walter de Gruyter, (19970000), pages 89 - 91 , 214, XP055539524-
OPPOSITION- "Protein Purification Handbook", Amersham Biosciences, (20011000), pages 19 - 23, XP055539579-
OPPOSITION- Takahashi, K. et al., "Aspartic Proteinases", Experimental Medicine and Biology, New York, (19950000), vol. 362, page 275, XP055539532-
OPPOSITION- GHOSE, S. et al., "Antibody: Variable Region Interactions with Protein A: Implications for the Development of Generic Purification Processes", Biotechnology and Bioengineering, (20051004), vol. 92, no. 6, pages 665 - 673, XP055378782
OPPOSITION- JUNGBAUER, A et al., "Pilot scale production of a human monoclonal antibody against human immunodeficiency virus", Journal of Biochemical l and Biophysical Methods, (19890100), vol. 19, pages 223 - 240, XP002114282
OPPOSITION- ARAKAWA, T et al., "Elution of antibodies from a Protein-A column by aqueous arginine solutions", Protein Expression and Purification, (20040520), vol. 36, no. 2, pages 244 - 248, XP004520288
OPPOSITION- VEJARATPIMOL, R. et al., "Detection and Serological Relationships of Cymbidium MosaicPotexvirus Isolates", Journal of Bioscience and Bioengineering, (19990000), vol. 87, no. 2, pages 161 - 168, XP055539536
OPPOSITION- GOEBL, N.A. et al., "Neonatal Fe Receptor Mediates Internalization of Fe in Transfected Human Endothelial Cells", Molecular Biology of the Cell, (20080000), vol. 19, no. 12, pages 5490 - 5505, XP055539484
SEARCH- JUNGBAUER A ET AL, "Pilot scale production of a human monoclonal antibody against human immunodeficiency virus", JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, AMSTERDAM, NL, (19890101), vol. 19, no. 2/03, doi:10.1016/0165-022X(89)90029-8, ISSN 0165-022X, pages 223 - 240, XP002114282 [X] 1-3,9,12-16 * sections "Optimization of the ion exchange chromatography" and "Chromatographic procedures"; page 235, line 7 - line 9 * [Y] 4-8,10,11

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents